PTM202 for the Treatment of Environmental Enteric Dysfunction (EED)
Pilot Study of PTM202 for the Treatment of Environmental Enteric Dysfunction (EED)
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to assess the effectiveness of PTM202 in treating environmental enteric dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2017
CompletedFirst Posted
Study publicly available on registry
August 28, 2017
CompletedStudy Start
First participant enrolled
October 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2019
CompletedApril 22, 2019
April 1, 2019
1.2 years
August 24, 2017
April 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EED biomarker composite score
composite score of fecal Reg 1B, fecal myeloperoxidase, urinary lactulose: mannitol ratio, serum soluable-CD14, and serum C-reactive protein
4 months
Secondary Outcomes (4)
Weight gain
4 months
Height gain
4 months
Number of diarrheal episodes
4 months
Glucose hydrogen breath test
4 months
Study Arms (2)
Intervention
EXPERIMENTALPTM202 and micro-nutrient sprinkles
Control
OTHERmicro-nutrient sprinkles
Interventions
Micro-nutrient sprinkles will be given twice daily for 30 days.
Eligibility Criteria
You may qualify if:
- Aged 6 - 9 months old
- \> Weight-for-age Z score \> -3
- Parental consent to participate and receive daily supplementation with either PTM202 and/or micro-nutrient sprinkles, participate in specimen collection
You may not qualify if:
- Presence of known kidney, liver, heart, developmental, or neurologic disease
- Allergy to milk and/or egg (assessed by history)
- Milk intolerance (assessed by history)
- Abnormal liver or kidney function tests
- Family is planning to move from the study area or children is enrolled to the other clinical trial within 3 months of follow up
- Child being exclusively breast fed at the time of enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
International Centre for Diarrhoeal Disease Research, Bangladesh
Dhaka, Bangladesh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2017
First Posted
August 28, 2017
Study Start
October 14, 2017
Primary Completion
December 30, 2018
Study Completion
February 15, 2019
Last Updated
April 22, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share